Verastem, Inc. (Nasdaq: VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today highlighted the company’s recent progress and outlined strategic priorities for 2019.
January 3, 2019
· 21 min read